BOCA RATON, Fla., Aug. 2, 2004 (PRIMEZONE) -- Pure H20 Bio-Technologies, Inc. (Pink Sheets:PHBT) announced today USBioSystems, Inc. accepted the engagement with PHBT to oversee further testing of Pure H20's newly engineered potable water point-of-use disinfection systems for hospitals, residential and commercial use.
Today's health concerns strongly suggest that there is a need for a more rigorous testing procedure that incorporates the measurement of disinfecting chlorine-resistant live organisms that may be potential etiological agents for water-borne disease. Pure H20 has outlined a series of studies that are strategic steps to advance its sales and marketing position. PHBT has taken these aggressive measures to position itself to exceed sales projections and secure strong cash flow.
USBioSystems (USBC) is the largest environmental testing laboratory in the state of Florida, holding multiple state and federal certifications including the National Environmental Laboratory Accreditation Program (NELAC), and is known for its commitment to high standard Quality Assurance/Quality Control Programs.
USBS will manage the Pure H20 testing programs to ensure proper control, analyses and maintain related data flow. "We feel that our relationship with USBioSystems will build additional customer confidence in the Pure H20 water disinfection technology," said Joseph Doxey, President of Pure H20 Bio-Technologies, Inc.
PHBT is a publicly held company specializing in the manufacturing, design and sale of its unique residential, commercial and hospital point-of use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass.
The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "will," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.